Pfizer, BioNTech Get New Shot To Ax Moderna's MRNA Patent
Pfizer and BioNTech have won another shot at challenging the validity of one of Moderna's key mRNA vaccines as a judge ruled Wednesday that their appeal had a reasonable prospect of...To view the full article, register now.
Already a subscriber? Click here to view full article